Researchers at Columbia Presbyterian Hospital in New York City are currently conducting a mesothelioma clinical trial to test a potential new treatment for mesothelioma. Patients who have enrolled will be given three therapeutic drugs--cisplatin, pemetrexed, and bevacizumab-which will be used together to see if this new drug combination has the potential to be a more effective form of treatment.
For patients to be eligible for this mesothelioma clinical trial, they must not have undergone prior chemotherapy for the treatment of mesothelioma or have been treated with any of the drugs under the consideration of this study. For this mesothelioma clinical trial, patients must also be willing to take B12 vitamin and folic acid supplements. New York City is the home of top cancer institutions such as Columbia Presbyterian Hospital. For more information about this hospital and its cancer treatments, please click on the following link: http://www.nyp.org/
Those interested in learning more about this new mesothelioma clinical trial testing the combination of Cisplatin, Pemetrexed, and Bevacizumab, please click on the following link: http://www.centerwatch.com/patient/studies/stu92726.html